{"id":"4cad3252-06ed-525c-b65c-df872d2a4bb7","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-olanzapine-smoking","predicate":"associated_with_lower","statement":"Median concentration-to-dose ratio was 6.0 in smokers versus 10.1 nmol/L/mg in nonsmokers.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"bea2f0c3-cdb9-55f6-bb0f-c6bd75905105","mechanism_event_label":"Smoking had a measured association; equal effects from DIM are not established.","subject":{"id":"afc266db-ebba-5318-abca-6655ee9cacca","slug":"cigarette-smoking-exposure","display_name":"Exposure to cigarette smoking","entity_type_key":"cellular_process"},"object":{"id":"aa2a9449-aef4-57ab-a9e5-0fd0fb5799c5","slug":"olanzapine-dose-normalized-concentration","display_name":"Dose-normalized serum olanzapine concentration","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"bea2f0c3-cdb9-55f6-bb0f-c6bd75905105","stable_key":"182336c6-ed36-5ec6-8a09-25c31096262e:dim-olanzapine-smoking-event","event_type":"observed_intervention","label":"Smoking had a measured association; equal effects from DIM are not established.","description":"Median concentration-to-dose ratio was 6.0 in smokers versus 10.1 nmol/L/mg in nonsmokers.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"e83902e5-cd44-5de2-b790-abf19033d265","slug":"olanzapine","display_name":"Olanzapine","entity_type_key":"small_molecule"},"role":"measured_drug","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"afc266db-ebba-5318-abca-6655ee9cacca","slug":"cigarette-smoking-exposure","display_name":"Exposure to cigarette smoking","entity_type_key":"cellular_process"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"aa2a9449-aef4-57ab-a9e5-0fd0fb5799c5","slug":"olanzapine-dose-normalized-concentration","display_name":"Dose-normalized serum olanzapine concentration","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/dim-research/37841771.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1f6834b6adcdbbdf02999b1bc5f567b8c0873f393d9b0e80127c887ab8054247\", \"start_char\": 0, \"end_char\": 1698, \"text_sha256\": \"1f6834b6adcdbbdf02999b1bc5f567b8c0873f393d9b0e80127c887ab8054247\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Cross-sectional therapeutic-concentration study","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"37 smokers; comparison with nonsmokers","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Observed smoking association, not randomized DIM exposure; confounding and individual variability remain.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"dim","display_name":"3,3'-Diindolylmethane / DIM","entity_type_key":"small_molecule"}},{"dimension":"organism","value_text":"58 outpatients with schizophrenia","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Smoking had a measured association; equal effects from DIM are not established.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[dim-p37841771] Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia. (2023). https://pubmed.ncbi.nlm.nih.gov/37841771/ DOI: 10.11613/bm.2023.030702","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Dose-normalized olanzapine concentrations","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"0aac810b-f228-5493-bec5-0191d2168be1","evidence_kind":"source_excerpt","locator":"Lines 753-764","start_line":753,"end_line":764,"excerpt":"### dim-olanzapine-smoking\nMedian concentration-to-dose ratio was 6.0 in smokers versus 10.1 nmol/L/mg in nonsmokers.\nCondition category: normal\nnutrient_topic: Diindolylmethane (DIM) research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Smoking had a measured association; equal effects from DIM are not established.\norganism: 58 outpatients with schizophrenia\ntissue_or_cell_type: Dose-normalized olanzapine concentrations\nexperimental_model: Cross-sectional therapeutic-concentration study\nlimitations: Observed smoking association, not randomized DIM exposure; confounding and individual variability remain.\nexposure: 37 smokers; comparison with nonsmokers\nevidence_span: {\"source_cache\": \"artifacts/dim-research/37841771.abstract.txt\", \"locator\": \"Primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1f6834b6adcdbbdf02999b1bc5f567b8c0873f393d9b0e80127c887ab8054247\", \"start_char\": 0, \"end_char\": 1698, \"text_sha256\": \"1f6834b6adcdbbdf02999b1bc5f567b8c0873f393d9b0e80127c887ab8054247\"}\n[dim-p37841771] Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia. (2023). https://pubmed.ncbi.nlm.nih.gov/37841771/ DOI: 10.11613/bm.2023.030702","model_system":"Cross-sectional therapeutic-concentration study","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [dim-p37841771] Association of smoking cigarettes, age, and sex with serum concentrations of olanzapine in patients with schizophrenia. (2023). https://pubmed.ncbi.nlm.nih.gov/37841771/ DOI: 10.11613/bm.2023.030702","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"b6d70682-97f9-5893-a03c-f9f88836033c","stable_key":"import-182336c6-ed36-5ec6-8a09-25c31096262e","title":"Diindolylmethane (DIM): formation, receptor signaling, metabolism and drug interactions (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"31e14060de904976d2f5d439f2bc9c8a99a72d34626c562c78429025e050d404","revision_id":"611094c1-a9cf-5b9b-b255-ac70b571696a","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}